Phreesia Long Term Debt 2019-2025 | PHR
Phreesia Annual Long Term Debt (Millions of US $) |
|
---|---|
2025 | $8 |
2024 | $5 |
2023 | $3 |
2022 | $7 |
2021 | $6 |
2020 | $22 |
2019 | $30 |
2018 | $0 |
Phreesia Quarterly Long Term Debt (Millions of US $) |
|
---|---|
2025-01-31 | $8 |
2024-10-31 | $10 |
2024-07-31 | $7 |
2024-04-30 | $9 |
2024-01-31 | $5 |
2023-10-31 | $7 |
2023-07-31 | $8 |
2023-04-30 | $7 |
2023-01-31 | $3 |
2022-10-31 | $4 |
2022-07-31 | $5 |
2022-04-30 | $6 |
2022-01-31 | $7 |
2021-10-31 | $5 |
2021-07-31 | $6 |
2021-04-30 | $6 |
2021-01-31 | $6 |
2020-10-31 | $24 |
2020-07-31 | $23 |
2020-04-30 | $22 |
2020-01-31 | $22 |
2019-10-31 | $21 |
2019-07-31 | $22 |
2019-04-30 | |
2019-01-31 | |
2018-10-31 | |
2018-07-31 | |
2018-01-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $1.385B | $0.420B |
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $38.151B | 48.75 |
Hims & Hers Health (HIMS) | United States | $11.939B | 124.05 |
Tempus AI (TEM) | United States | $9.210B | 0.00 |
IRhythm Technologies (IRTC) | United States | $4.513B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.137B | 64.64 |
Privia Health (PRVA) | United States | $2.813B | 192.25 |
Enovis (ENOV) | United States | $1.861B | 10.37 |
Clover Health Investments (CLOV) | United States | $1.593B | 0.00 |
Schrodinger (SDGR) | United States | $1.579B | 0.00 |
Omnicell (OMCL) | United States | $1.376B | 24.27 |
Azenta (AZTA) | United States | $1.241B | 57.66 |
10x Genomics (TXG) | United States | $1.091B | 0.00 |
Butterfly Network (BFLY) | United States | $0.650B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.626B | 0.00 |
Talkspace (TALK) | United States | $0.495B | 148.00 |
Veradigm (MDRX) | United States | $0.460B | 0.00 |
Claritev (CTEV) | United States | $0.438B | 0.00 |
Standard BioTools (LAB) | United States | $0.414B | 0.00 |
TruBridge (TBRG) | United States | $0.358B | 793.33 |
Outset Medical (OM) | United States | $0.346B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
Health Catalyst (HCAT) | United States | $0.256B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.191B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.135B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.132B | 0.00 |
Pulmonx (LUNG) | United States | $0.119B | 0.00 |
American Well (AMWL) | United States | $0.109B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.100B | 0.00 |
CareCloud (CCLD) | United States | $0.087B | 3.31 |
111 (YI) | China | $0.068B | 0.00 |
HeartBeam (BEAT) | United States | $0.054B | 0.00 |
P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
Zhongchao (ZCMD) | China | $0.028B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
Precipio (PRPO) | United States | $0.015B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Movano (MOVE) | United States | $0.004B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |